Antineoplastics: reaching phase III RCTs linked to eventual success

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1636, 2008-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decision Making from Phase II to Phase III and the Probability of Success: Reassured by “Assurance”?

By Carroll Kevin J.

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 1188-1200

Taylor & Francis Ltd

Access to resources Recommend Favorite

RCTs rarely mention drug costs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 612, 2010-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Synthesis of Diverse Asparagine Linked Oligosaccharides and Synthesis of Sialylglycopeptide on Solid Phase

Current Medicinal Chemistry, Vol. 12, Iss. 5, 2005-03 ,pp. : 527-550

Bentham Science Publishers

Access to resources Recommend Favorite

Phase III ATENA Trial of Exemestane Discontinued

By Sweetlove Mel

Pharmaceutical Medicine, Vol. 26, Iss. 1, 2012-02 ,pp. : 45-47

Adis International

Access to resources Recommend Favorite

Phase III CONCERT Trial of Latrepirdine: Negative Results

By Sweetlove Mel

Pharmaceutical Medicine, Vol. 26, Iss. 2, 2012-04 ,pp. : 113-115

Adis International

Access to resources Recommend Favorite